Cetera Investment Advisers Bio Rad Laboratories, Inc. Transaction History

Cetera Investment Advisers

  • $44.2 Billion
  • Q3 2024

A detailed history of Cetera Investment Advisers transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 1,688 shares of BIO stock, worth $570,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,688
Previous 2,015 16.23%
Holding current value
$570,088
Previous $550,000 2.55%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$263.97 - $344.64 $86,318 - $112,697
-327 Reduced 16.23%
1,688 $564,000
Q2 2024

Aug 22, 2024
SELL
$268.26 - $339.48 $138,422 - $175,171
-516 Reduced 20.39%
2,015 $550,000
Q1 2024

May 24, 2024
BUY
$304.11 - $351.99 $558,650 - $646,605
1,837 Added 264.7%
2,531 $875,000
Q1 2024

May 14, 2024
SELL
$304.11 - $351.99 $245,416 - $284,055
-807 Reduced 53.76%
694 $240,000
Q4 2023

Feb 13, 2024
SELL
$269.37 - $365.04 $175,629 - $238,006
-652 Reduced 30.28%
1,501 $484,000
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $208,048 - $251,042
594 Added 38.1%
2,153 $771,000
Q2 2023

Aug 09, 2023
SELL
$359.49 - $486.4 $37,386 - $50,585
-104 Reduced 6.25%
1,559 $591,000
Q1 2023

May 15, 2023
SELL
$418.69 - $503.0 $8,373 - $10,060
-20 Reduced 1.19%
1,663 $796,000
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $86,168 - $111,722
245 Added 17.04%
1,683 $707,000
Q3 2022

Nov 10, 2022
BUY
$412.59 - $563.26 $275,197 - $375,694
667 Added 86.51%
1,438 $1,000
Q2 2022

Aug 11, 2022
SELL
$463.67 - $597.16 $185,931 - $239,461
-401 Reduced 34.22%
771 $382,000
Q1 2022

May 13, 2022
SELL
$524.57 - $735.42 $110,159 - $154,438
-210 Reduced 15.2%
1,172 $660,000
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $232,499 - $260,655
328 Added 31.12%
1,382 $1.04 Million
Q3 2021

Nov 16, 2021
SELL
$657.71 - $825.77 $67,744 - $85,054
-103 Reduced 8.9%
1,054 $786,000
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $164,342 - $184,976
285 Added 32.68%
1,157 $745,000
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $209,504 - $253,680
383 Added 78.32%
872 $498,000
Q4 2020

Feb 17, 2021
BUY
$510.68 - $643.45 $249,722 - $314,647
489 New
489 $285,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email